Ping An Trust

Ping An Insurance (Group) Company of China, Ltd., established in 1988 in Shenzhen, is a leading personal integrated financial services provider in China. As the first insurance company in the country to adopt a shareholding structure, Ping An has evolved to encompass three core businesses: insurance, banking, and investment. The company aims to foster the parallel growth of its traditional and non-traditional financial ventures. In its traditional business, Ping An focuses on creating a financial supermarket and enhancing customer migration. Concurrently, it seeks to innovate within non-traditional sectors by seamlessly integrating financial services into everyday life, covering areas such as health, housing, and entertainment. The Group strives to establish an integrated financial services platform that offers a comprehensive customer experience, promotes sustainable profit growth, and ensures long-term stability for its shareholders.

Donald Lacey

Chief Investment Officer, Global Voyager Fund

Dong Liu

Principal Partner

Mingzhe Ma

Chairman and CEO

Sun Yong

Managing Director

Tian Tuo Ph.D

Managing Director

132 past transactions

Hangzhou Yingde Gas

Corporate Round in 2024
Hangzhou Yingde Gas is a company that specializes in the manufacturing and sales of industrial automatic control system devices and electrical signal equipment.

Soterea

Series B in 2022
Soterea is a software company based in Tianjin, China, founded in 2014. The company specializes in the development of intelligent driving technology for commercial vehicles, aiming to enhance driving safety. Soterea's innovations include a high-precision sensing system, automatic braking features, and a cloud platform designed to assist drivers in avoiding incidents on the road.

Rain Med

Series D in 2021
Rain Med is a vascular interventional surgical robot developer focused on the development of coronary angiography systems.

Xgene Pharmaceutical

Series C in 2021
Xgene Pharmaceutical Inc. is a late-clinical stage pharmaceutical company established in 2015, based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Utilizing proprietary linker technology, Xgene creates novel, multimodal conjugated molecules that enhance the efficacy and tolerability of pain medications. The company's current programs are dedicated to addressing unmet needs in neurological disorders, making significant strides in the development of innovative treatments for these conditions.

Biren Technology

Series B in 2021
Biren Technology is a high-tech startup specializing in the design and development of intelligent processors tailored for GPU and DSA computation architectures. The company focuses on creating integrated software and hardware platforms that support intelligent computing applications, including cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing. With a dedicated team of industry experts and elite engineers, Biren Technology aims to deliver versatile computing solutions that blend general computing capabilities with specific applications. Its research division is committed to advancing key technologies in intelligent computing systems, emphasizing new architectures and advanced compilation techniques, thereby facilitating technological breakthroughs in various high-tech sectors.

MitrAssist

Venture Round in 2020
MitrAssist is a company focused on developing innovative solutions for mitral valve regurgitation (MR). It has created a minimally invasive mitral valve implant that enhances the functionality of the natural mitral valve without causing damage. This unique "valve-in-valve" approach allows the implant to work in harmony with the existing valve, offering a treatment option that is neither a repair nor a replacement. MitrAssist's technology addresses the challenges associated with MR and aims to provide a more effective treatment solution for patients. By improving upon current minimally invasive methods, MitrAssist seeks to deliver significant advantages in patient care and outcomes.

Apollomics

Series C in 2020
Apollomics, Inc. is an emerging life sciences company based in Foster City, California, focused on developing innovative oncology therapies aimed at targeting the growth and proliferation of cancer cells. Founded in 2016, the company’s pipeline includes several development-stage assets, such as CBT-101, an oral agent that targets the epithelial to mesenchymal transition pathway associated with various tumors, and CBT-102, which inhibits the MAP Kinase pathway and angiogenesis through its effects on specific receptors. Additionally, Apollomics is advancing monoclonal antibodies CBT-501 and CBT-502, which target the PD-1 and PDL-1 membrane receptors, respectively, to enhance the immune response against cancer. By combining immune-based strategies with targeted therapies, Apollomics aims to develop novel treatments that can effectively combat cancer.

Lepu Bio

Series B in 2020
Lepu Biotechnology Co., Ltd. is a Chinese biotech company specializing in tumor immunotherapy. Founded in 2018, it has developed an industrial platform dedicated to target discovery, drug preparation, development, and manufacturing. The company focuses on creating drug candidates that include programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) antibodies, an oncolytic virus, and various antibody-drug conjugates (ADCs). Lepu Bio's core products are currently in clinical stages I to III, demonstrating its commitment to advancing cancer treatment through innovative biopharmaceutical solutions.

DentaLink China

Series C in 2020
Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.

Wind

Funding Round in 2019
Wind Information is recognized as the leading firm in financial data, information services and solutions in China. We are dedicated to providing accurate and real-time data, as well as sophisticated information platforms for financial professionals.

Lixiangjia

Series D in 2019
The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high net worth families. Professional overseas asset reconfiguration plan.

Shijiazhuang Junlebao Dairy

Funding Round in 2019
Shijiazhuang Junlebao Dairy is a prominent dairy products company based in China, specializing in a diverse array of offerings that include fluid milks, flavored milk, yogurt, baby formula, and milk powder. The company has developed a comprehensive operational framework that encompasses the entire dairy industry chain, ensuring coordinated development and a focus on nutrition, health, and safety for its consumers. By prioritizing quality and innovation, Junlebao Dairy aims to meet the growing demand for dairy products in the market while promoting the well-being of its customers.

iTutorGroup

Acquisition in 2019
iTutorGroup is an online education provider founded in 1998, headquartered in Taipei City, Taiwan, with additional offices in Shanghai, China, and Santa Clara, California. The company offers a range of platforms designed for both students and business professionals, including VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English language learning, as well as TutorMing for Mandarin Chinese language instruction. Additionally, iTutorGroup provides LiveH2H, a service for live translations in multiple languages. The company focuses on delivering individualized and personalized learning experiences, allowing instructors to tailor content to meet the specific needs of learners.

Lenovo Healthcare Information Technology (Lenovo HIT)

Corporate Round in 2019
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.

Global Data Solutions

Post in 2019
Global Data Solutions Limited is a data center operator based in Shanghai, China, with additional facilities in Beijing, Chengdu, Shenzhen, Kunshan, and Guangzhou. Founded in 2000 by William Wei Huang, the company specializes in designing, building, and managing data centers, providing services such as colocation, managed hosting, and managed cloud solutions. It offers information technology outsourcing services, including business continuity and disaster recovery, which encompass planning, design, implementation, and operation. The company primarily serves clients in the Internet and banking sectors, as well as a range of industries including finance, energy, manufacturing, aviation, telecommunications, and large corporations, both domestic and multinational. Global Data Solutions aims to deliver high-quality infrastructure and support to enhance operational efficiency and reliability for its diverse customer base across the Asia-Pacific region.

Zhangshang Tangyi

Series C in 2019
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Xiaoqule

Series A in 2018
Xiaoqule is a community-focused e-commerce platform based in Hangzhou, China, and operates as a subsidiary of Zhejiang Gejia Network Technology Co., Ltd. The platform connects local businesses with consumers, facilitating the purchase of cost-effective products and services, including seasonal fruits and vegetables, imported snacks, and group ordering options. By shortening transportation times and ensuring the quality of goods, Xiaoqule enhances the shopping experience for local communities. Additionally, Xiaoqule provides logistical support, encompassing transportation, technology, marketing, and customer service, thereby enabling users to interact with their communities while conveniently fulfilling their purchasing needs.

Global Scanner

Series A in 2018
Global Scanner is a social e-commerce platform targeting the middle-class in China.

NextCure

Series B in 2018
NextCure, Inc. is a clinical-stage biopharmaceutical company based in Beltsville, Maryland, that specializes in the discovery and development of novel immunomedicines aimed at treating cancer and other immune-related diseases. The company focuses on restoring normal immune function through its lead product candidate, NC318, currently in Phase 2 clinical trials for advanced or metastatic solid tumors. In addition, NextCure is developing NC410, an immunomedicine designed to inhibit immune suppression mediated by Leukocyte-Associated Immunoglobulin-like Receptor 1. The company's research also includes preclinical programs targeting various immunomodulatory proteins associated with tumors and inflamed tissues. NextCure has established collaborations, including a licensing agreement with Yale University and a research partnership with Eli Lilly and Company, to further its innovative therapeutic approaches. Founded in 2015, NextCure is dedicated to advancing first-in-class immunotherapy solutions.

Xgene Pharmaceutical

Series B in 2018
Xgene Pharmaceutical Inc. is a late-clinical stage pharmaceutical company established in 2015, based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Utilizing proprietary linker technology, Xgene creates novel, multimodal conjugated molecules that enhance the efficacy and tolerability of pain medications. The company's current programs are dedicated to addressing unmet needs in neurological disorders, making significant strides in the development of innovative treatments for these conditions.

Lenovo Healthcare Information Technology (Lenovo HIT)

Series A in 2018
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.

Jinjiang Environment

Post in 2018
Jin Jiang Environmental Holdings Limited is China's leading waste to energy operators.The company has successfully embarked on a road of environmentally-friendly energy industrialization that combines production, learning

Grab Financial Group

Venture Round in 2018
Grab Financial Group provides financial services across payments, rewards, lending, and insurance. A seamless point-of-sale (POS) system for merchants and a trusted mobile wallet of choice in Southeast Asia for payments such as in-store purchases, Grab transactions, and fund transfers.

Grab

Series H in 2018
Grab Holdings Inc. is a prominent online-to-offline service provider based in Singapore, focusing on mobile technology solutions for transportation across Southeast Asia. Founded in 2012 by Anthony Tan and Tan Hooi Lng, Grab integrates various transportation services through its platform, which includes offerings such as GrabTaxi, GrabCar, GrabHitch, GrabShare, GrabCoach, GrabShuttle, GrabShuttle Plus, GrabFamily, JustGrab, GrabNow, and GrabRental. The company operates in multiple countries, including Singapore, Indonesia, the Philippines, Malaysia, Thailand, Vietnam, and Myanmar. In addition to its headquarters in Singapore, Grab has offices in Seattle, Beijing, Bangalore, Jakarta, and Vietnam, further extending its reach and capabilities within the region.

Chemclin

Private Equity Round in 2018
Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its services encompass a range of clinical inspection instruments, including chemiluminescence and biochemical reagents, as well as technical support, management, and certification. Additionally, Chemclin operates independent medical laboratories and is focused on introducing innovative diagnostic products and services to the Chinese market.

HashFish

Angel Round in 2018
HashFish provides bitcoin mining software and services.

JollyChic

Series C in 2018
JollyChic is a comprehensive e-commerce platform founded in 2012 by Aaron Li, headquartered in China. It specializes in the online retail of a diverse range of consumer products, including clothing, accessories, electronics, home goods, baby products, and more. The platform aims to provide customers with a variety of quality and stylish items, catering to various needs and preferences. By facilitating cross-border transactions, JollyChic enables shoppers to access suitable offers while ensuring decent quality in the products available for purchase.

Tmunity

Series A in 2018
Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, focused on developing innovative immunotherapies for cancer, infectious diseases, and autoimmune conditions. Founded in 2015, Tmunity specializes in creating engineered T cells, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg), utilizing proprietary technologies to activate, expand, and genetically modify T cells sourced from peripheral blood, cord blood, and tumors. The company aims to harness the potential of T cells to provide personalized next-generation treatments and is advancing its clinical programs in various disease areas. Tmunity's team is comprised of experts in T-cell biology, regulatory affairs, and clinical development, with a strong track record in executing successful cell and gene therapy trials. Additionally, Tmunity has established a robust manufacturing platform that supports multi-center clinical studies across diverse therapeutic indications.

Hua Medicine

Series D in 2018
Hua Medicine is a clinical-stage drug development company based in Pudong, China, specializing in innovative therapies for diabetes and central nervous system (CNS) disorders. Founded in 2009 by experienced professionals in the pharmaceutical industry, the company is advancing its lead product, Dorzagliatin, an oral medication for Type 2 diabetes, which has reached the NDA enabling stage and is currently undergoing two Phase 3 trials in drug-naive and metformin-treated patients in China. Additionally, Hua Medicine is exploring mGLUR5, a novel drug candidate aimed at treating levodopa-induced dyskinesia in Parkinson's disease. The company has secured funding from prominent international venture capital firms and has in-licensed global rights to its diabetes drug, positioning itself as a key player in the treatment landscape for these chronic conditions.

Rani Therapeutics

Venture Round in 2018
Rani Therapeutics, LLC is a clinical-stage biotherapeutics company that focuses on the development of oral delivery technologies for large drug molecules, such as peptides, proteins, and antibodies. The company has created the RaniPill capsule, a proprietary and patented platform designed to administer biologics orally, offering a convenient alternative to traditional subcutaneous or intravenous injections. This capsule is engineered to deliver precise therapeutic doses upon reaching the small intestine. Rani Therapeutics is advancing various treatments, including TNFa inhibitors for inflammatory disorders, parathyroid hormone for osteoporosis, and human growth hormone for growth deficiencies. Additionally, their portfolio includes therapies for multiple sclerosis, type II diabetes, and various inflammatory diseases. Founded in 2012 and based in San Jose, California, Rani Therapeutics has conducted several preclinical and clinical studies to assess the safety and effectiveness of its technologies, building a robust intellectual property portfolio in the process.

TytoCare

Series C in 2018
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

Tmunity

Series A in 2018
Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, focused on developing innovative immunotherapies for cancer, infectious diseases, and autoimmune conditions. Founded in 2015, Tmunity specializes in creating engineered T cells, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg), utilizing proprietary technologies to activate, expand, and genetically modify T cells sourced from peripheral blood, cord blood, and tumors. The company aims to harness the potential of T cells to provide personalized next-generation treatments and is advancing its clinical programs in various disease areas. Tmunity's team is comprised of experts in T-cell biology, regulatory affairs, and clinical development, with a strong track record in executing successful cell and gene therapy trials. Additionally, Tmunity has established a robust manufacturing platform that supports multi-center clinical studies across diverse therapeutic indications.

Kbp Biosciences

Series A in 2018
KBP Biosciences is a biotechnology research and development organization focused on creating innovative therapies for unmet medical needs, particularly in the fields of cardiovascular, respiratory, inflammatory, and autoimmune diseases. The company specializes in the research, development, and commercialization of new medicines, leveraging its expertise in medicinal chemistry and clinical development. By addressing gaps in treatment options, KBP aims to provide healthcare providers with effective solutions for managing conditions that currently lack adequate therapies.

StartUp Health

Venture Round in 2018
StartUp Health, founded in 2011 and based in San Francisco, is a venture capital investment firm dedicated to improving global health and wellbeing. The firm collaborates with a network of entrepreneurs known as Health Transformers to pursue ambitious health goals, referred to as health moonshots. These include improving access to care, reducing costs, curing diseases, addressing various health issues such as cancer, women's and children's health, nutrition and fitness, brain health, mental health, addiction, longevity, and pandemic response. StartUp Health boasts the largest health innovation portfolio in the world, comprising over 330 companies across 26 countries and six continents. The firm is supported by a diverse range of prominent investors from the healthcare and technology sectors, reflecting its commitment to fostering innovation in health.

Rogrand

Series C in 2017
Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.

Chexiang

Series B in 2017
Chexiang is a Chinese online-to-offline automotive trading platform operated by Shanghai-based SAIC Motor Co. Ltd. The platform is designed to serve the automotive needs of consumers in China, offering services that include renting, buying, sharing, or booking vehicles at competitive prices. By facilitating these transactions, Chexiang aims to enhance the travel experience for its users, providing convenient access to various automotive options.

Fullerton Healthcare Corporation

Venture Round in 2017
Fullerton Health is a prominent provider of corporate healthcare solutions in the Asia Pacific region, operating a network of over 225 fully-owned medical centres and more than 8,000 medical providers. Headquartered in Singapore, the company employs around 2,000 individuals, including over 1,200 healthcare professionals. Fullerton Health specializes in managed care, network management, primary care, and secondary care, ensuring that patients receive efficient and cost-effective healthcare services. The organization also operates six call centres across five countries, enhancing its capability to deliver comprehensive support and services to its clients.

Tikin Media

Angel Round in 2017
Tikin Media is an innovative advertising company that specializes in elevator marketing solutions, connecting property owners with advertisers. The company installs advanced commercial projectors in elevators, creating a unique advertising platform that enhances consumer exposure to brands. Tikin Media has attracted significant investment from major players in the industry, including Baidu Venture Capital, Sequoia China, and IDG. With a focus on high-end commercial building media operations, Tikin Media has developed proprietary elevator projection technology that transforms traditional advertising methods, enabling mobile interconnectivity and incorporating programmatic ordering and big data analysis capabilities.

MitrAssist

Venture Round in 2017
MitrAssist is a company focused on developing innovative solutions for mitral valve regurgitation (MR). It has created a minimally invasive mitral valve implant that enhances the functionality of the natural mitral valve without causing damage. This unique "valve-in-valve" approach allows the implant to work in harmony with the existing valve, offering a treatment option that is neither a repair nor a replacement. MitrAssist's technology addresses the challenges associated with MR and aims to provide a more effective treatment solution for patients. By improving upon current minimally invasive methods, MitrAssist seeks to deliver significant advantages in patient care and outcomes.

Annoroad

Series C in 2017
Annoroad Gene Technology, established in 2012 and headquartered in Beijing, is a prominent player in China's genomics sector, known primarily for its Non-Invasive Prenatal Testing (NIPT) services and advanced genomic research capabilities. The company specializes in next-generation sequencing (NGS) technologies applied to human health and life science research. Annoroad has received multiple accolades, including recognition as a national high-tech enterprise and a pilot organization for high-throughput sequencing clinical applications. It boasts a comprehensive product portfolio that includes the NextSeq 550AR sequencer and various genomic testing reagents, supporting diagnostic applications in human reproduction, oncology, and rare diseases. Additionally, Annoroad has developed SolarGenomics, a cloud-based platform for genomic big data services, and has established robust research and development capabilities, reinforced by a skilled workforce. The company's extensive service offerings span the entire genomics industry chain, enhancing its reputation and fostering partnerships within the sector.

Prenetics

Series B in 2017
Prenetics Limited is a DNA biotechnology company based in Central, Hong Kong, specializing in pharmacogenomics and health sciences. The company offers the iGenes PGx test, which assists physicians in determining the appropriate medication and dosage for patients based on their genetic profiles while identifying potential adverse drug effects. In addition to pharmacogenomics, Prenetics provides ONEdna, a DNA screening service that delivers insights and actionable recommendations based on an individual’s genetic makeup. Its consumer health initiative is represented by the IM8 brand, while the clinical division includes Insighta, which focuses on multi-cancer early detection technologies, and ACT Genomics, known for its FDA-approved genomic profiling of solid tumors. Prenetics has formed strategic partnerships with notable organizations, including The Lippo Group and New Horizon Health Limited. The company was established in 2007 and underwent a name change from Multigene Diagnostics Limited to Prenetics Limited in November 2014.

Che Youyuan

Series A in 2017
Che Youyuan provides assistance services to the majority of car owners at any time, any place, and any vehicle. Rescue service products and peripheral products include towing service, telephone service, tire replacement service, field repair, dianbao, multi tool pen, and rescue t-shirt

Huya.com

Series A in 2017
Huya.com is China's interactive broadcast platform, enriched by the world's first communications service operators. The company's live products cover PC, Web, and mobile three-end, and have nearly 300 featured channels in 4 categories including online games, single-game hot games, mobile games, and entertainment variety, covering e-sports, music, sports, beauty, outdoor, A wide range of popular content such as reality shows, variety shows, entertainment, and food.

Aiqi Technology

Series A in 2017
Beijing AIQI Technology Co., Ltd. is an Internet technology company focused on the research and development of artificial intelligence and robotic technology. The company has assembled a team of enthusiastic and innovative individuals dedicated to exploring advancements in intelligent equipment, resulting in the acquisition of numerous patents over the past three years. A notable achievement includes a partnership with a prominent technology firm, positioning AIQI as the sole provider of DIY intelligent robots within that company's ecosystem. AIQI specializes in creating interactive DIY family robots designed for K-12 STEM education, leveraging advanced AI technology to enhance human-machine interaction. Their products are user-friendly, updatable, and aim to inspire creativity while providing engaging experiences for users in modern life.

Global Switch Holdings

Secondary Market in 2016
Global Switch is a leading operator of large-scale, carrier-neutral data centers, owning and managing approximately 3,000,000 square feet of space across Europe and the Asia-Pacific region. Established in 1998, the company has built a strong reputation for delivering reliable and efficient data center solutions tailored to the needs of a diverse clientele, including government agencies, financial institutions, enterprises, and global systems integrators. Global Switch emphasizes strategically located facilities that offer high resilience and low latency, positioning its data centers near key urban centers and internet hubs to optimize connectivity and service delivery for its customers.

TapTap

Series A in 2016
TapTap is an online platform dedicated to gaming enthusiasts, serving as both a community hub and a marketplace for game downloads and purchases. It facilitates interaction among users while providing access to a diverse range of games, catering to various interests and preferences within the gaming community. By combining social features with a robust selection of games, TapTap aims to enhance the gaming experience and foster connections among players.

Innovent Biologics

Series D in 2016
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacturing, and commercialization of monoclonal antibodies. The company focuses on therapeutic areas such as oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody approved for treating various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's pipeline includes several important candidates, such as IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma, and IBI-303, an adalimumab biosimilar for autoimmune diseases. The company is also developing innovative therapies for conditions like hypercholesterolemia and various cancers. With a robust portfolio of commercialized products and ongoing strategic collaborations with major pharmaceutical companies, Innovent aims to expand its impact in the global biopharmaceutical landscape. Founded in 2011, Innovent is recognized as one of China's leading biotechnology firms.

Gegejia.com

Series A in 2016
Gegejia, operated by Zhejiang Grid Network Technology Co., Ltd., is an e-commerce platform specializing in the sale of imported food products. Launched on March 26, 2015, the company quickly gained traction, processing over 10,000 orders within its first 30 days, generating millions in revenue. Gegejia partners with renowned international food brands to offer high-quality and carefully selected food items to Chinese consumers. The core team at Gegejia brings extensive e-commerce experience, with each member having between five to ten years in the industry, contributing to the company's strong resource network and operational expertise.

Fe3 Medical

Series B in 2016
Fe3 Medical, Inc., operating as Bria Medical, specializes in developing transdermal therapies aimed at treating iron deficiency anemia. The company has created a disposable transdermal patch that delivers around 10 milligrams of iron directly through the skin, effectively bypassing the gastrointestinal tract and minimizing side effects commonly associated with oral iron supplements. Primarily targeting women, Fe3 Medical focuses on providing a safe and non-toxic solution for individuals suffering from this condition. Established in 2008, the company is headquartered in San Antonio, Texas.

Nanopep

Seed Round in 2016
Nanopep is a nano-biomedical company focused on advancing cancer prevention and precision medicine through innovative technologies. The company develops platform technologies that facilitate personalized medicine, including SPRI and MALDI-TOF MS microarrays for high-throughput peptide screening. Additionally, Nanopep specializes in the enrichment of circulating tumor cells using nano-beads, which underpins its protein-based liquid biopsy assay. The company targets three primary user groups: it provides preventative detection services for healthy individuals, assesses and identifies risks for patients with tumors, and offers treatment solutions for those with PD-L1 expression. Through these efforts, Nanopep aims to improve early detection and treatment outcomes in oncology.

Wanjia

Angel Round in 2016
Wanjia provides dentistry, chinese medicine, pediatrics, and gynaecology services. They provide services for children and adults. Their customers' inquiries are addressed through phone, email, and online applications.

Zhuanhua Yixue Wang

Series A in 2016
Zhuanhua Yixue Wang is a translational medicine portal for gene testing, cell therapy, in vitro diagnosis, precision medicine, and other core segments of translational medicine that provide original content and in-depth industry analysis. They provide news reports for doctors, researchers, enterprises, and related practitioners with the goal of leading the development of the industry. They offer services for forums, salons, and training courses.

Fabric Genomics (formerly Omicia)

Series B in 2016
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

Applied StemCell

Series D in 2016
Applied StemCell Inc. is a biotechnology company specializing in animal and cell line models that facilitate drug discovery and diagnostics. The company employs its proprietary TARGATT gene modification technology to efficiently create site-specific Knockin mouse, rat, and human cell line models, catering to both pharmaceutical and academic researchers. Applied StemCell focuses on developing and commercializing various models, including Knockin, Knockout, and Transgenic mouse models, humanized mouse models, and gene-modified human cell lines derived from induced pluripotent stem cells. Additionally, the company offers optimized stem cell culture products and gene engineering solutions for mammalian cells. By continuously enhancing its technologies and expanding its product offerings, Applied StemCell aims to support the evolving needs of the biomedical community and advance next-generation biomedical research.

Rogrand

Series B in 2016
Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.

Shenchu Jia Yan

Angel Round in 2016
Shenchu Jia Yan is an online restaurant reservation platform.

F-ROAD

Series E in 2016
Shanghai F-road Commercial Services Co., Ltd. specializes in mobile financial services tailored for financial institutions. Founded in 2008 and based in Shanghai, the company provides a variety of offerings, including encrypted mobile banking, daily online services, community bank development and operation, as well as asset management for regional banks. F-road also plays a crucial role in promoting inclusive finance by assisting the transformation and upgrading of regional banks and activating grassroots financial organizations. Utilizing advanced technologies such as big data, cloud platforms, and artificial intelligence, F-road delivers comprehensive solutions through two platforms—a local life platform and a smart credit platform—alongside eID operation services, enhancing the financial capabilities of regional banks.

AutoHome

Acquisition in 2016
Autohome Inc. is the leading online destination for automobile consumers in China, established in 2008 as a media content platform. It operates two primary websites, autohome.com.cn and che168.com, which offer extensive, independent, and interactive content tailored for automobile buyers and owners. The platform ranks first among automotive service sites in terms of mobile daily active users and has a significant market presence, holding a 30% share in online automotive advertising and lead generation services. Autohome's extensive user base makes it an attractive platform for automakers and dealers, who utilize its advertising services for brand promotion, new model launches, and sales campaigns. Additionally, its dealer subscription services enable dealers to effectively market their inventory and services, significantly broadening the reach of their physical showrooms to millions of potential customers across China.

Meidaila1221

Series B in 2016
Meidaila is a computer software company offering technology solutions.

Prenetics

Series A in 2016
Prenetics Limited is a DNA biotechnology company based in Central, Hong Kong, specializing in pharmacogenomics and health sciences. The company offers the iGenes PGx test, which assists physicians in determining the appropriate medication and dosage for patients based on their genetic profiles while identifying potential adverse drug effects. In addition to pharmacogenomics, Prenetics provides ONEdna, a DNA screening service that delivers insights and actionable recommendations based on an individual’s genetic makeup. Its consumer health initiative is represented by the IM8 brand, while the clinical division includes Insighta, which focuses on multi-cancer early detection technologies, and ACT Genomics, known for its FDA-approved genomic profiling of solid tumors. Prenetics has formed strategic partnerships with notable organizations, including The Lippo Group and New Horizon Health Limited. The company was established in 2007 and underwent a name change from Multigene Diagnostics Limited to Prenetics Limited in November 2014.

Fe3 Medical

Series B in 2016
Fe3 Medical, Inc., operating as Bria Medical, specializes in developing transdermal therapies aimed at treating iron deficiency anemia. The company has created a disposable transdermal patch that delivers around 10 milligrams of iron directly through the skin, effectively bypassing the gastrointestinal tract and minimizing side effects commonly associated with oral iron supplements. Primarily targeting women, Fe3 Medical focuses on providing a safe and non-toxic solution for individuals suffering from this condition. Established in 2008, the company is headquartered in San Antonio, Texas.

JMDNA

Series B in 2016
JMDNA (Shanghai) Bio-Medical Technology Co., Ltd., established in 2011 and headquartered in Shanghai, China, specializes in molecular diagnostics with a focus on women and children. The company provides a range of research and application services, including non-invasive genetic testing and diagnostics for liver diseases and tumors. JMDNA aims to deliver comprehensive and precise genetic testing solutions that enable early diagnosis of hereditary conditions and diseases affecting mothers and children. By collaborating with medical institutions and industry partners, JMDNA is dedicated to advancing clinical applications and improving healthcare outcomes in its specialized field.

Yunda Express

Private Equity Round in 2016
Yunda's business is mainly express delivery business, but also includes warehousing business and supply chain business. As of December 31, 2019, Yunda's service network covers 31 provinces (regions, municipalities) and Hong Kong, Macao, and Taiwan regions across the country, reaching more than 30 countries and regions around the world, and providing high-quality lifestyle experiences for domestic and foreign customers. The company is one of the first batches of 44 private enterprise headquarters in Shanghai. It has been included in the BrandZ Top 100 Most Valuable Chinese Brands list twice, and successively won honors such as "2014-2015 National Civilized Unit in Transportation Industry". Yunda was included in the MSCI China Index and ranked among the top three in the "2018 China United 100" ranking.

Rani Therapeutics

Venture Round in 2016
Rani Therapeutics, LLC is a clinical-stage biotherapeutics company that focuses on the development of oral delivery technologies for large drug molecules, such as peptides, proteins, and antibodies. The company has created the RaniPill capsule, a proprietary and patented platform designed to administer biologics orally, offering a convenient alternative to traditional subcutaneous or intravenous injections. This capsule is engineered to deliver precise therapeutic doses upon reaching the small intestine. Rani Therapeutics is advancing various treatments, including TNFa inhibitors for inflammatory disorders, parathyroid hormone for osteoporosis, and human growth hormone for growth deficiencies. Additionally, their portfolio includes therapies for multiple sclerosis, type II diabetes, and various inflammatory diseases. Founded in 2012 and based in San Jose, California, Rani Therapeutics has conducted several preclinical and clinical studies to assess the safety and effectiveness of its technologies, building a robust intellectual property portfolio in the process.

Oscar Health

Private Equity Round in 2016
Oscar Health is a health insurance company based in New York, founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser. It specializes in offering individual and family health insurance plans, Medicare Advantage programs for seniors, and small group products. Oscar Health aims to enhance the healthcare experience by leveraging technology, design, and data to make services more accessible and user-friendly. The company primarily serves individuals, couples, and families who do not receive employer-sponsored health insurance in select states, including New York, New Jersey, California, and Texas. In addition to traditional insurance offerings, Oscar provides virtual care, doctor support, and appointment scheduling, emphasizing a comprehensive approach to healthcare management.

YICHUAN

Angel Round in 2016
YICHUAN is a men's lifestyle media services company.

Bochewang

Series B in 2016
Bochewang is a professional B2B trading platform that specializes in motor cars and accessories, catering to auto repair shops, dismantle shops, used car dealers, and parts sellers. The platform comprises three main sections: an auction center for selling accident and used vehicles, a vehicle showroom for trading repaired used cars, and an accessories platform for exchanging various auto parts. Bochewang's online service facilitates second-hand car auctions and provides essential parts and financial services, allowing users to conduct transactions efficiently and effectively. To access the platform's features, users must complete registration, payment, and authentication.

20/20 Gene Systems

Series A in 2016
20/20 GeneSystems Inc. is a biotechnology company based in Rockville, Maryland, focused on developing and commercializing diagnostic tests for the early detection of cancer. The company offers several products, including PAULA’s Test, a blood test for lung cancer detection, and OneTest, which screens for multiple cancer types, such as lung, liver, and pancreatic cancers. Additionally, 20/20 provides BioCheck, a detection kit for screening suspicious powders, and Layered ImmunoHistoChemistry, which predicts the efficacy of targeted cancer therapies. The firm also offers CoronaCheck Tests, specializing in COVID-19 antibody testing. With a commitment to reducing cancer mortality, 20/20 GeneSystems employs advanced biomarker technologies and collaborates with various health agencies and organizations to enhance cancer diagnostics and promote personalized medicine.

Zhangshang Tangyi

Series B in 2016
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Xieche.com

Series B in 2016
Xieche.com offers comprehensive automobile maintenance and repair services tailored for car owners. Their extensive range of services includes sheet metal painting, electromechanical repair, improving air conditioning efficiency, oil changes, and tire rim cleaning. Xieche emphasizes customer education by providing detailed information about each maintenance process, fostering transparency in car care. Additionally, the company offers convenient options for maintenance, enabling customers to choose between home service and in-store repairs, ensuring that car owners can easily access the services they need to keep their vehicles in optimal condition.

Kangzhi Pifuyisheng

Series A in 2015
Kangzhi Pifuyisheng is an online consultation service platform.

Alchemy Information

Angel Round in 2015
ALCHEMY INFORMATION is a provider of game art services tailored for the gaming industry, specializing in 3D art production, animation, and visual effects for various platforms, including PC, AAA consoles, and mobile devices. The company focuses on outsourcing game art to support game development companies, ensuring high-quality production that meets the needs of its clients. With a commitment to delivering self-developed entertainment products, ALCHEMY INFORMATION aims to enhance the gaming experience for a global audience.

Black & White Campus

Series A in 2015
Black & White Campus is a company that specializes in campus promotion activities and provides a mobile social application tailored for students. This application serves as a platform where students can engage in discussions and organize meet-ups on various topics, fostering a sense of community and connectivity within educational environments. By focusing on the unique needs of the student demographic, Black & White Campus aims to enhance social interaction and collaboration among peers.

MOGU

Series E in 2015
MOGU is an consumer platform aimed towards women, achieved through e-commerce, social media, influencers and content driven services. Their content covers all areas of the fashion world and they have a huge range of age groups and interest covered through their numerous apps and platform. MOGU Inc. is a destination of fashion. With various kinds of fashion content and abundant fashion products, MOGU Inc. allows people to discover and share fashion trends while fully enjoying high-quality shopping experience. In 2011, MOGU Inc. launched fashion platform under the Mogujie brand . In 2016, the merger of Mogujie and Meilishuo was completed.Currently, MOGU Inc.'s online platform includes Mogujie.com and Meilishuo.com websites, mogujie mobile app, Meilishuo mobile app, Uni mobile app and several WeChat Mini programs.

Anxin Doctor

Series A in 2015
Anxin Doctor operates a mobile healthcare platform focused on maternal and pediatric health. It connects patients with obstetricians, gynecologists, and pediatricians, facilitating access to specialized medical care. The platform allows users to receive healthcare advice and book clinical appointments through its application, thereby enhancing health outcomes for patients. By bridging the gap between healthcare professionals and patients, Anxin Doctor aims to streamline the process of accessing essential medical services in the fields of maternal and child health.

NCARS

Angel Round in 2015
NCARS provides chain services such as machine repair, body spraying, insurance, and accident vehicle. They offer brand marketing management, accessories supply chain, technician training, and service management.

Rakunew

Corporate Round in 2015
Rakunew is an e-commerce company that offers a range of gadgets and new products that are popular overseas. The company is an international mail-order company that sells innovative household items and gadgets that are well-liked abroad but hard to find in Japan.

Qukaidan

Series B in 2015
Enterprise service

Zhangshang Tangyi

Series A in 2015
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

58 Daojia

Series A in 2015
58 Daojia operates an online platform that offers access to various high-quality household services, including cleaning, moving, babysitting, and beauty care, across approximately 30 cities in China. Founded in September 2014, the platform utilizes a location-based order processing system to efficiently connect users with independent service providers nearby. This approach enables customers to easily access a range of essential services, facilitating a more comfortable home life.

Clinicloud

Seed Round in 2015
CliniCloud, Inc. is a healthcare technology company based in San Francisco, California, that develops a connected medical kit aimed at empowering users to monitor various health indicators such as fever, cough, and respiratory conditions. Founded by physicians Dr. Hon Weng Chong and Dr. Andrew Lin, CliniCloud initially launched as "StethoCloud," featuring a smart stethoscope and later expanded its offerings to include a non-contact thermometer, recognizing the importance of temperature in diagnostics. The connected medical kit includes a digital stethoscope, a non-contact thermometer, and a mobile application that records high-fidelity audio, enabling users to track symptoms and share their health data with medical professionals for timely evaluations. CliniCloud aims to facilitate proactive health management and equip patients with the necessary tools for informed healthcare decisions, marking a shift towards more patient-centered care.

Ativa Medical

Series B in 2015
Ativa Medical Corporation is a medical device manufacturing company focused on developing and commercializing point of care testing diagnostic products tailored for decentralized healthcare settings. Founded in 2008 and headquartered in Saint Paul, Minnesota, the company specializes in providing analyzers that conduct essential hematology and clinical chemistry tests, along with disposable test cards designed for trauma, pediatric, oncology, and geriatric patients. Ativa Medical aims to deliver diagnostic test results in moments rather than hours or days, serving a diverse range of clients, including hospital departments, physician's offices, and remote healthcare clinics across the globe.

Payoneer

Series E in 2015
Payoneer Inc. is a financial technology company that operates a cross-border payments platform designed to facilitate transactions for businesses and professionals worldwide. Founded in 2005 and headquartered in New York, Payoneer's services include the Global Payment Service, which allows users to receive local bank transfers from various countries directly into their Payoneer accounts. The platform also supports mass payouts, enabling companies, particularly in India, to transfer funds internationally. Payoneer caters to a diverse clientele, including freelancers, e-commerce businesses, and online advertising companies, and has established strategic partnerships to enhance its service offerings. Through its innovative solutions, Payoneer aims to empower small and medium-sized enterprises in the global digital commerce landscape.

Beijing Express Channel Cold Chain Logistics Co.

Series A in 2015
Beijing Express Channel Cold Chain Logistics Co., Ltd., located in Beijing, China, specializes in providing logistics solutions focused on cold chain services. The company offers a range of services, including cold chain urban distribution, less-than-truckload transportation, and home delivery options. By delivering economical and suitable cold chain logistics solutions, the company aims to meet the diverse needs of its customers in ensuring the safe and efficient transport of temperature-sensitive goods.

Secoo

Series E in 2015
Secoo is a luxury products and services platform based in China, facilitating global trade between buyers and suppliers through both online and offline channels. The company operates an online retail platform and experience centers in key cities such as Beijing, Shanghai, Chengdu, and others, as well as in Malaysia. Secoo collaborates with renowned brand boutiques, allowing customers to pick up products ordered online at physical locations. The majority of its revenue is derived from its online business, with a significant focus on the Chinese market. Established in 2011, Secoo has built a substantial membership base of 500,000, including over 20,000 VIP members. The company aims to enhance its presence by establishing exhibition centers in major cities, further solidifying its position in the luxury retail sector.

Didi

Private Equity Round in 2015
Didi Chuxing, founded in 2012 in Beijing, is a leading mobile transportation platform providing app-based services such as taxi hailing, private car-hailing, social ride-sharing, car rental, and enterprise solutions. With over 450 million users and daily orders reaching 25 million, Didi offers a variety of mobility options to optimize resource allocation through big data-driven algorithms. The company aims to address transportation, environmental, and employment challenges by collaborating with communities and partners. Acquiring Uber China in 2016, Didi has over 21 million drivers and car owners on its platform, generating income while offering convenient transportation solutions to users worldwide.

Bochewang

Series A in 2015
Bochewang is a professional B2B trading platform that specializes in motor cars and accessories, catering to auto repair shops, dismantle shops, used car dealers, and parts sellers. The platform comprises three main sections: an auction center for selling accident and used vehicles, a vehicle showroom for trading repaired used cars, and an accessories platform for exchanging various auto parts. Bochewang's online service facilitates second-hand car auctions and provides essential parts and financial services, allowing users to conduct transactions efficiently and effectively. To access the platform's features, users must complete registration, payment, and authentication.

Rogrand

Series A in 2015
Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.

Purple Clinic

Series A in 2015
Purple Clinic operates a WeChat-based doctor-patient service platform tailored to meet the specific needs of medical partners. The platform facilitates communication between doctors and patients through an online medical mobile application, enhancing consultation services in various fields including dermatology, pediatrics, gynecology, andrology, and internal medicine. By integrating digital marketing project management with medical services, Purple Clinic aims to streamline the interaction between healthcare providers and patients, ultimately improving the quality of care and accessibility of medical advice.

Medbanks

Series A in 2015
Medbanks Network Technology, founded in 2014 and based in Beijing, specializes in data processing services for the healthcare sector. The company focuses on developing an oncology database that compiles clinical and professional medical service information gathered from hospitals. This resource aims to enhance the understanding and management of cancer care. In addition, Sipai Health Technology Co Ltd operates within the medical technology and health management space in China, encompassing three main segments: specialty pharmacy, physician research assistance, and health insurance services. The specialty pharmacy segment is the primary revenue driver, while the company predominantly conducts its business within the People's Republic of China.

eXiche

Series A in 2015
eXiche provide users with Internet booking to the shop car wash, door car wash services.

9F Group

Series B in 2015
9F Group is a Chinese fintech platform established in 2006, boasting over 68 million registered users, primarily utilizing its mobile applications. The company offers a diverse array of financial services, including online lending, wealth management, and payment facilitation, all accessible through a personalized digital financial account. Its various brands, such as 9F Onecard, 9F Wallet, Wukong Wealth, and Wecash, cater to the financial needs of users throughout different life stages. 9F Group emphasizes the use of mobile Internet and big data risk management technologies to enhance service efficiency and quality. Additionally, the company has invested in over ten internet finance startups to explore future technological advancements. As a founding member and board member of the National Internet Finance Association of China, 9F is actively involved in shaping the regulatory landscape of the fintech industry in the country. The majority of its revenue is derived from loan facilitation services within China.

Rainbow Medical Innovation

Venture Round in 2015
Rainbow Medical Innovation is a private operational company established in 2007 and based in Herzliya, Israel. It focuses on seeding and developing companies that create innovative medical devices, primarily those invented by Yossi Gross. The company aims to address significant unmet needs in various medical fields, contributing to advancements in healthcare while fostering the growth of its portfolio companies. By concentrating on breakthrough technologies, Rainbow Medical Innovation seeks to deliver substantial returns for its investors.

Trina Solar

Convertible Note in 2015
Trina Solar Co., Ltd. is an integrated manufacturer of solar power products and a developer of solar systems, with operations spanning China, Europe, the United States, and other regions in Asia Pacific. Established in 1997 and headquartered in Changzhou, China, the company specializes in designing, manufacturing, and selling a range of photovoltaic (PV) modules, including monocrystalline and multicrystalline types, suitable for residential, commercial, and industrial applications. Trina Solar also produces silicon ingots, wafers, and cells, and offers services related to the construction and management of solar power projects. The company serves a diverse clientele that includes power plant developers, distributors, and grid operators, positioning itself as a significant player in both the domestic and global solar markets. Additionally, Trina Solar is involved in smart energy solutions, encompassing the operation and management of photovoltaic power stations and the development of smart microgrid systems.

WanJiangLong

Series A in 2015
Wanjianglong operates in the internet and commercial real estate sectors, providing comprehensive operational service solutions for commercial real estate projects. Their offerings encompass all stages of construction, opening, and ongoing operations, aimed at enhancing the performance of commercial complexes. By facilitating the attraction of new customers, promoting engagement, retaining existing clients, and boosting sales, Wanjianglong helps commercial properties thrive. Additionally, the company develops software focused on consumer data collection and analysis, which assists shopping center merchants in understanding customer preferences. This enables businesses to create targeted marketing strategies, ultimately expanding their customer base and improving sales outcomes.

Qukaidan

Series B in 2014
Enterprise service

Mogoroom

Series A in 2014
Mogoroom currently operates in Shanghai and Beijing, providing standardized rental apartments to young professionals seeking more convenient living environment services.

Qiaobu Jianli

Series A in 2014
Qiaobu Jianli provides online portal services for resume templates to students. They offer black and white resume templates and colour resume templates. Thye also offer industries related resume templates such as communication , biology, pharmaceutical, civil engineering.

eToro

Series D in 2014
eToro is a global multi-asset investment platform founded in 2007, based in London. It empowers individuals to grow their knowledge and wealth by providing a social trading network that allows users to trade various assets including currencies, commodities, indices, crypto assets, and stocks. eToro's platform enables users to manually invest in different asset classes or automatically copy the trades of other successful traders within its community of over 23 million registered users. The company operates as a subsidiary of eToro Group Limited.

Black & White Campus

Angel Round in 2014
Black & White Campus is a company that specializes in campus promotion activities and provides a mobile social application tailored for students. This application serves as a platform where students can engage in discussions and organize meet-ups on various topics, fostering a sense of community and connectivity within educational environments. By focusing on the unique needs of the student demographic, Black & White Campus aims to enhance social interaction and collaboration among peers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.